NCT03851159View on ClinicalTrials.gov

Nyaditum Resae® as a Co-adjuvant During Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut Microbiota

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 10, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Tuberculosis

Interventions

DIETARY_SUPPLEMENT

Nyaditum resae®

Heat-killed Mycobacterium manresensis

OTHER

Mannitol

Placebo

Trial Locations (2)

7570

Scottsdene Clinic, Cape Town

Wallacedene Clinic, Cape Town

All Listed Sponsors

collaborator

Fundació Institut Germans Trias i Pujol

OTHER

lead

University of Stellenbosch

OTHER

NCT03851159 - Nyaditum Resae® as a Co-adjuvant During Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut Microbiota | Biotech Hunter | Biotech Hunter